Get the green light for your new drug. The U.S. Food and Drug Administration (FDA) has approved Pfizer’s new blood cancer drug. The drug, called Elrexfio, is a subcutaneous therapy for patients with drug-resistant multiple myeloma, an aggressive and so far incurable blood cancer, according to a statement released by the company.
This drug is indicated for adult patients with multiple myeloma who have relapsed after receiving at least four lines of certain treatments.. The U.S. pharmaceutical company highlighted that use of the therapy in patients who had previously received four or more lines of other therapy achieved an overall response rate of 58% with Elrexfio, and an estimated 82% of patients maintained remission at least 1 year. At least 9 months.
Injected under the skin, the drug is a mature antigen for B cells that help fight myeloma cells.. Angela Hwang, chief commercial officer and president of Pfizer’s biopharmaceutical business, said: “With the remarkable response in the patient population with highly refractory disease, we believe that Elrexfio has the potential to become a new standard of care for multiple myeloma.”
Multiple myeloma is the second most common type of blood cancer.
Multiple myeloma is the second most common type of blood cancer, with more than 35,000 new cases diagnosed each year in the United States and more than 176,000 new cases worldwide.
Pfizer says the therapy’s maximum revenue potential could exceed $4 billion. In addition, the U.S. company warned that the most common side effects of treatment with the drug were cytokine release syndrome, fatigue, injection site reactions, diarrhea, upper respiratory infection, musculoskeletal pain, pneumonia, decreased appetite, rash, cough, Nausea, and fever.
U.S. Pharmaceuticals’ net profit in the second quarter was US$2.327 billion, a decrease of 77% from the same period in 2022. The company’s turnover also declined during the period, with a turnover of 12.534 billion euros between April and June, a decrease of 54% from a year ago, which is directly related to the decline in the company’s sales. Sales of Covid-19 products, vaccines and antivirals.
Pfizer is a New York-based pharmaceutical company founded in 1849 by Charles Pfizer and Charles Erhart. Although its first product was Santonin, a drug that fights parasites in the worm family, Pfizer is also known for launching Viagra into the market.